📊 Score Breakdown
Offering Ability
30
Cash Runway
0
Float Risk
14
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
20%
🔄 Reverse Split
30%
• 50-day avg $1.89 approaching $1 threshold
💰 Capital Raise
18%
• Active ATM program with $118M remaining capacity
💹 Market Data
Market Cap$254.32M
Shares Outstanding134.56M
Float107.02M
Cash$140.32M
Debt$8.51M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.9% shares (2025Q4 vs prior)
56 institutional holders · 30.01M shares
#1
venBio Partners LLC
9.70M shares
#2
MILLENNIUM MANAGEMENT LLC
3.30M shares
#3
Redmile Group, LLC
3.26M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.21M
Days to Cover1.9
% of Float2.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2020
3
FORM3
Apr 17, 2026
4
INSIDER TRANSACTION
Apr 17, 2026
4
INSIDER TRANSACTION
Apr 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ALXO
📊 ALXO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ALXO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.